Concluding remarks and outlook for the use of 5-HT3 receptor antagonists in rheumatology.

1. Non-infectious arthritides of different origins. As far as these diseases are concerned, the most efficacious dosages still need to be ascertained for different types of arthritides and varying degrees of severity. 2. Activated osteoarthritis and other processes, which are associated with articular pain and inflammation, for example conditions after articular operations like arthroscopic meniscus surgery. 3. Localized soft tissue rheumatic processes: a) Tendinopathies b) Bursopathies c) Trigger points with myofascial syndromes and tendomyopathies.